Breaking News Instant updates and real-time market news.

ORCL

Oracle

$49.59

0.08 (0.16%)

, PBR

Petrobras

$11.70

0.23 (2.01%)

07:35
01/17/18
01/17
07:35
01/17/18
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Tuesday in Oracle (ORCL), Petrobras (PBR), Applied Materials (AMAT), Celgene (CELG), Kinder Morgan (KMI), Kodak (KODK), MGM Resorts (MGM), Praxair (PX), Pretium Resources (PVG), and Pan American Silver (PAAS).

ORCL

Oracle

$49.59

0.08 (0.16%)

PBR

Petrobras

$11.70

0.23 (2.01%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

KMI

Kinder Morgan

$19.39

-0.13 (-0.67%)

KODK

Kodak

$8.50

-0.7 (-7.61%)

MGM

MGM Resorts

$36.03

1 (2.85%)

PX

Praxair

$162.10

-2.05 (-1.25%)

PVG

Pretium Resources

$11.65

0.5 (4.48%)

PAAS

Pan American Silver

$17.24

0.58 (3.48%)

  • 17

    Jan

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 21

    Feb

  • 25

    Mar

ORCL Oracle
$49.59

0.08 (0.16%)

01/03/18
01/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Mills (GIS) upgraded to Neutral from Underweight at Piper Jaffray with analyst Michael Lavery saying he expects the company to use some of its tax reform benefit to increase "needed" brand investments. He sees the company posting 9%-10% average earnings growth over the next six quarters. 2. Ulta Beauty (ULTA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying he sees "compelling setup" for the shares in 2018 given the company's "material" tax benefit and potential for fundamental stabilization. 3. IBM (IBM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Amit Daryanani citing the benefits of the mainframe cycle upgrade, a favorable FX backdrop for the first time in 3 years, recovery in hybrid IT spending leading to 1%-3% revenue growth, and attractive 11-times PE valuation. 4. Oracle (ORCL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss arguing that its current low valuation with cloud expectations diminished following its last three earnings reports presents "a tactical opportunity for old fashioned earnings growth to drive the shares higher." 5. United Technologies (UTX) upgraded to Outperform from Sector Perform at RBC Capital analyst Deane Dray saying 2018 will mark the final year of margin pressure at the company's Pratt and Otis units which led to the recent underperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/18
01/03/18
UPGRADE
Target $57

Overweight
Morgan Stanley gives five reasons to go long Oracle
As previously reported, Morgan Stanley analyst Keith Weiss upgraded Oracle to Overweight from Equal Weight, arguing that its current low valuation with cloud expectations diminished following its last three earnings reports presents "a tactical opportunity for old fashioned earnings growth to drive the shares higher." As five reasons to be long, Weiss points to: the database cycle being in "full swing"; expectations being reset for its SaaS applications; the fact that Oracle's effective tax rate is likely coming down; the positive impact of repatriation; and its current valuation looks inexpensive compared to the stock's historical ranges. Weiss raised his price target on Oracle shares to $57 from $50.
01/03/18
MSCO
01/03/18
UPGRADE
MSCO
Overweight
Oracle upgraded to Overweight from Equal Weight at Morgan Stanley
01/02/18
DRXL
01/02/18
NO CHANGE
Target $62
DRXL
Buy
Drexel Hamilton says buy Oracle dip as Information report seems like 'fake news'
Drexel Hamilton analyst Brian White believes that The Information's report claiming that Salesforce (CRM) and Amazon (AMZN) are moving away from using Oracle (ORCL) databases is inaccurate, he tells investors in a note entitled "AMZN and CRM to Dump Oracle? - Sounds Like Fake News to Us." The analyst, who said he would be a buyer of Oracle on weakness driven by the report, noted that there have been similar stories about Salesforce in the past that turned out to be false, as he believes is the case again here. He maintains a Buy rating and $62 price target on Oracle shares.
PBR Petrobras
$11.70

0.23 (2.01%)

10/18/17
SOCG
10/18/17
DOWNGRADE
SOCG
Hold
Petrobras downgraded to Hold from Buy at Societe Generale
Societe Generale analyst John Herrlin downgraded Petrobras to Hold from Buy citing valuation and maintained a $10.50 price target.
09/01/17
DBAB
09/01/17
UPGRADE
DBAB
Hold
Petrobras upgraded to Hold from Sell at Deutsche Bank
03/24/17
SOCG
03/24/17
UPGRADE
SOCG
Buy
Petrobras upgraded to Buy from Hold at Societe Generale
Societe Generale upgraded Petrobras to Buy with a $11.50 price target saying the company has lowered capex and controllable costs and will be increasing production growth in 2017.
03/28/17
HSBC
03/28/17
UPGRADE
HSBC
Buy
Petrobras upgraded to Buy from Hold at HSBC
HSBC analyst Lily Yang upgraded Petrobras to Buy with an $11.50 price target.
AMAT Applied Materials
$54.50

1.05 (1.96%)

01/08/18
01/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Technologies (UTX) upgraded to Buy from Neutral at Goldman Sachs with analyst Noah Poponak saying he believes United Technologies is within the year of maximum new engine loss on Geared Turbofan engines, or GTFs, and thinks the market will begin to look beyond that peak loss and give increased consideration to substantial longer-term cash flows. 2. Caterpillar (CAT) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying she believes the stock still has "significant upside" despite the outperformance in 2017. 3. Flir Systems (FLIR) upgraded to Buy from Hold at SunTrust with analyst Michael Ciarmoli citing the company's realigned segment structure under the new management team with a sharper focus on the larger government and industrial end-markets, forecasting outperformance driven by RAID order flow and new Department of Defense procurement initiatives. 4. Applied Materials (AMAT) upgraded to Strong Buy from Buy at Needham with analyst Y. Edwin Mok saying he is positive on the company's "balanced WFE exposure across segments" amid the likelihood of moderating NAND growth. 5. Western Union (WU) upgraded to Neutral from Negative at Susquehanna with analyst James Friedman saying he believes the company may be working with Ripple Labs to potentially implement blockchain applications in remittance and sees that as a possible accelerator with business-to-business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
NEED
01/08/18
UPGRADE
Target $72
NEED
Strong Buy
Applied Materials upgraded to Strong Buy from Buy at Needham
Needham analyst Y. Edwin Mok upgraded Applied Materials to Strong Buy from Buy and raised his price target to $72 from $66, naming the company his "favorite large-cap SemiCap" for this year. The analyst is positive on the company's "balanced WFE exposure across segments" amid the likelihood of moderating NAND growth. Mok also anticipates potential growth upside if investment in China ramps faster than his projections, forecasting "increased sustainability of growth and improved visibility to CY20" supporting stock price gains.
01/16/18
SUSQ
01/16/18
UPGRADE
SUSQ
Positive
Applied Materials upgraded to Positive from Neutral at Susquehanna
01/16/18
SUSQ
01/16/18
UPGRADE
Target $72
SUSQ
Positive
Applied Materials upgraded to Positive at Susquehanna
As previously reported, Susquehanna analyst Mehdi Hosseini upgraded Applied Materials to Positive from Neutral. The analyst said his positive view of the industry combined with his favorable view on the display sector caused him to raise his estimates and price target on Applied Materials and thus upgrade the shares. Hosseini raised his price target to $72 from $60 on Applied Material shares.
CELG Celgene
$104.82

-1.18 (-1.11%)

01/09/18
JEFF
01/09/18
NO CHANGE
Target $125
JEFF
Buy
Celgene likely 'too cheap and oversold,' says Jefferies
Jefferies analyst Michael Yee says that at 12 times earnings estimates, shares of Celgene are "probably too cheap and oversold." After meeting with management, Yee believes the company will do more deals following yesterday's acquisition of Impact. Further, he sees a potential share rebound on more pipeline readouts in 2018-2019. The analyst keeps a Buy rating on Celgene with a $125 price target.
01/09/18
BMOC
01/09/18
NO CHANGE
Target $147
BMOC
Outperform
Celgene 2018 outlook deliberately conservative, says BMO Capital
BMO Capital analyst M. Ian Somaiya says Celgene's 2018 guidance is "deliberately conservative", reflecting the management's decision to reduce the risk to near-term estimates amid investor focus on the company pipeline. Somaiya notes that investor focus is shifting to business development and the potential for more deals in the near-term as well as the data from the company's 12 phase III trials this year. The analyst keeps his Outperform rating and $147 price target on Celgene.
01/16/18
SBSH
01/16/18
NO CHANGE
SBSH
Buy
Juno could be worth $110 per share in takeover, says Citi
After the Wall Street Journal reported tonight that Celgene (CELG) is in talks to acquire Juno Therapeutics (JUNO), Citi analyst Robyn Karnauskas says her analysis indicates Juno could be worth $110 per share in a takeover. The stock in after-hours trading jumped 43%, or $19.50, to $65.10. The analyst, however, points that Kite Pharma had more data at the time of acquisition and was acquired by Gilead Sciences (GILD) for an aggregate price of $11.9B. Karnauskas also notes that Celgene already downs 25% of June's revenues.
01/17/18
JEFF
01/17/18
NO CHANGE
Target $125
JEFF
Buy
Jefferies believes $8B price tag makes sense for Juno Therapeutics
Jefferies analyst Michael Yee says that if Celgene (CELG) paid $65-$90 per share for Juno Therapeutics (JUNO), or a 50%-100% premium to the "unaffected" price before yesterday, it would equate to $7B-9B in enterprise value to consolidate. The analyst believes an $8B deal makes sense since Celgene owns 10% of Juno already. Assuming a $65-$90 per share deal price, the Street would view Juno as a positive "incremental" acquisition for Celgene, Yee tells investors in a research note. He keeps a Buy rating on Celgene with a $125 price target.
KMI Kinder Morgan
$19.39

-0.13 (-0.67%)

01/11/18
01/11/18
UPGRADE

Overweight
TransCanada upgraded on defensive positioning, valuation at Morgan Stanley
As previously reported, Morgan Stanley analyst Tom Abrams upgraded TransCanada (TRP) to Overweight from Equal Weight as he believes Midstream valuations are now more defensibly attractive and he prefers the companies in the space with some defensive characteristics. He also has Overweight ratings on Williams (WMB), Williams Partners (WPZ), Enterprise Products (EPD) and Kinder Morgan (KMI).
01/11/18
WELS
01/11/18
DOWNGRADE
Target $21
WELS
Market Perform
Kinder Morgan downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Michael Blum downgraded Kinder Morgan to Market Perform and cut his price target for the shares to $21 from $24. The combination of "still persistently high" leverage and the headline risk associated with the TransMountain pipeline expansion project could weigh on shares, Blum tells investors in a research note.
01/09/18
BOFA
01/09/18
INITIATION
Target $20
BOFA
Neutral
Kinder Morgan reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Dennis Coleman reinstated coverage on Kinder Morgan with a Neutral and $20 price target.
01/04/18
FBCO
01/04/18
INITIATION
Target $23
FBCO
Outperform
Kinder Morgan initiated with an Outperform at Credit Suisse
Credit Suisse analyst Kristina Kazarlan initiated Kinder Morgan with an Outperform rating and a price target of $23. The analyst says the valuation suggests the MLP may not need a direct catalyst, adding that "a quiet but well-executed 2018" justifies the rating.
KODK Kodak
$8.50

-0.7 (-7.61%)

MGM MGM Resorts
$36.03

1 (2.85%)

01/04/18
DBAB
01/04/18
NO CHANGE
Target $183
DBAB
Buy
Deutsches says Wynn Resorts 'the one to buy' in Gaming
Deutsche Bank analyst Carlo Santarelli raised his price target for Wynn Resorts (WYNN) to $183 from $170 and says the stock is the "one to buy" in Gaming. The analyst believes "late cycle dynamics could become clearer" in 2018 regarding Las Vegas trends and he prefers to play the "hot hand." He thinks Wynn can outperform and keeps a Buy rating on the shares. Santarelli also raised his price target for Hold-rated MGM Resorts (MGM) to $38 from $37 and for Hold-rated Las Vegas Sands (LVS) to $65 from $63.
01/16/18
MSCO
01/16/18
NO CHANGE
MSCO
Morgan Stanley raises 2018 Macau gaming revenue growth forecast to 16%
Morgan Stanley analyst Thomas Allen raised his 2018 Macau gaming revenue growth forecast to 16% from 11%, noting that Q4 revenue growth of 20% topped his expectation for growth of 15% and he sees an opportunity for "lower tier" Chinese cities to support faster growth. Among casino names, Allen names Wynn Resorts (WYNN) as his top pick in U.S. Gaming and Lodging, calling MGM Resorts (MGM) his next favorite stock in the space. Other publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS) and Melco Resorts (MLCO).
11/22/17
UBSW
11/22/17
NO CHANGE
UBSW
UBS raises Macau estimates after positive survey
UBS analyst Robin Farley said the firm's proprietary Macau survey suggests better than expected junket trends and a further increase in VIP capacity, with higher end mass gaming revenue outpacing low end mass. The analyst raised estimates on the Macau gaming companies, noting that she prefers Wynn (WYNN) and Melco Resorts & Entertainment (MLCO) shares.
01/09/18
JPMS
01/09/18
NO CHANGE
Target $44
JPMS
Overweight
JPMorgan calls MGM 'best absolute value' in gaming for 2018
MGM Resorts offers the gaming sector's most attractive risk/reward for 2018, JPMorgan analyst Joseph Greff tells investors in a research note. Following stock rallies in the sector last year, MGM is now the "best absolute value play," the analyst adds. He views expectations as reasonable and upped his price target for the stock to $44 from $41. Greff keeps an Overweight rating on MGM Resorts.
PX Praxair
$162.10

-2.05 (-1.25%)

11/17/17
JPMS
11/17/17
NO CHANGE
Target $172
JPMS
Overweight
Praxair price target raised to $172 from $156 at JPMorgan
JPMorgan analyst Jeffrey Zekauskas raised his price target for Praxair (PX) to $172 and keeps an Overweight rating on the name. The analyst estimates the combined Praxair/Linde company is currently being valued at $145 per share. Should Praxair trade at parity to Air Products (APD), the new Praxair would be worth $172 per share, Zekauskas tells investors in a research note. He believes, however, that Praxair is capable of trading at a one multiple point premium to Air Products, which he thinks could yield a higher $189 per share value.
12/19/17
DBAB
12/19/17
UPGRADE
Target $175
DBAB
Buy
Praxair upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst David Begleiter upgraded Praxair to Buy and raised his price target for the shares to $175 from $155. The analyst expects "substantial value creation" from the merger with Linde. Begleiter highlights the company's accelerating volume growth over the last three quarters and improved pricing discipline in the industrial gas industry. He also has increased confidence that "New Linde" can achieve its $1B of targeted cost savings.
12/15/17
UBSW
12/15/17
NO CHANGE
Target $176
UBSW
Buy
Praxair price target raised to $176 from $160 at UBS
UBS analyst John Roberts raised his price target for Praxair shares to $176 on the expectation that Linde will create "significant value" through margin improvement, portfolio reshaping and benefit from an improvement in gas prices. The analyst assumes the deal closes and keeps a Buy rating on Praxair.
11/13/17
11/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. J.M. Smucker (SJM) upgraded to Positive from Neutral at Susquehanna with analyst Pablo Zuanic saying he believes the rout of food stocks is ebbing and since this company is the worst performing stock in his coverage universe, he chose to play the food trade with it. 2. Delek US (DK) upgraded to Strong Buy from Outperform at Raymond James with analyst Justin Jenkins saying it will benefit from a wider Brent-WTI spread. 3. Nvidia (NVDA) upgraded to Market Perform from Underperform at BMO Capital with analyst Ambrish Srivastava saying the company has demonstrated a "far stronger" data center business than he had forecast and its leverage is greater than anticipated. 4. Praxair (PX) upgraded to Buy from Hold at Argus with analyst Bill Selesky saying the company is well positioned to deliver stronger Earnings Per Share growth thanks to its mix of high-growth businesses driving above-industry-average margins, earnings, and returns on invested capital. 5. TD Ameritrade (AMTD) upgraded to Buy from Hold at Deutsche Bank with analyst Brian Bedell saying trading volumes are improving, trade pricing will hold up better than expected and the Scottrade integration is going very well. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PVG Pretium Resources
$11.65

0.5 (4.48%)

03/20/17
FBCO
03/20/17
INITIATION
Target $13.5
FBCO
Outperform
Pretium Resources initiated with an Outperform at Credit Suisse
Credit Suisse analyst Robert Reynolds started Pretium Resources with an Outperform rating and $13.50 price target.
10/12/17
CIBC
10/12/17
UPGRADE
CIBC
Outperformer
Pretium Resources upgraded to Outperformer from Neutral at CIBC
10/11/17
ROTH
10/11/17
NO CHANGE
Target $17
ROTH
Buy
Roth Capital raises Pretium price target to $17 after production report
After Pretium Resources announced production results from its Brucejack Mine that were "well above expectations" for the mine's first full quarter, Roth Capital analyst Joe Reagor raised his price target on the stock to $17 from $16. The analyst, who sees this update underscoring that Brucejack is a world class mine and that Pretium is "significantly undervalued," keeps a Buy rating on the stock.
10/11/17
SCOT
10/11/17
UPGRADE
SCOT
Outperform
Pretium Resources upgraded to Outperform from Sector Perform at Scotiabank
Scotiabank upgraded Pretium Resources to Outperform citing the positive Q3 production update.
PAAS Pan American Silver
$17.24

0.58 (3.48%)

11/22/17
11/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Kellogg (K) upgraded to Buy from Hold at Argus with analyst David Coleman saying that despite the challenging operating environment, the company will benefit from diminishing currency headwinds and new product launches in the coming quarters. 2. Dominion (D) upgraded to Buy from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith citing improved prospects for a tax reform resolution at VEPCO and expectations for improved execution. 3. Pan American Silver (PAAS) upgraded to Outperform from Neutral at Credit Suisse with analyst Robert Reynolds saying the 4% pullback in shares since the third quarter results provides an attractive valuation and entry point. 4. New Jersey Resources (NJR) upgraded to Buy from Neutral at Janney Capital. 5. Terreno Realty (TRNO) upgraded to Buy from Neutral at National Securities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
SCOT
01/08/18
UPGRADE
SCOT
Outperform
Pan American Silver upgraded to Outperform from Sector Perform at Scotiabank
11/22/17
FBCO
11/22/17
UPGRADE
Target $25
FBCO
Outperform
Pan American Silver upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Robert Reynolds upgraded Pan American Silver to Outperform and raised his price target for the shares to C$25 from C$24. The 4% pullback in shares since the Q3 results provides an attractive valuation and entry point, Reynolds tells investors in a research note following the company's investor day.
11/21/17
RAJA
11/21/17
UPGRADE
Target $19.5
RAJA
Outperform
Pan American Silver upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Brian MacArthur upgraded Pan American Silver to Outperform citing the recent pullback in shares.

TODAY'S FREE FLY STORIES

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

16:26
02/24/18
02/24
16:26
02/24/18
16:26
Hot Stocks
Buffett believes Berkshire can handle $400B mega-catastrophe »

In his annual letter to…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

16:19
02/24/18
02/24
16:19
02/24/18
16:19
Periodicals
Buffet says laments inability to find targets for Berkshire to buy, Reuters says »

Warren Buffett lamented…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

16:16
02/24/18
02/24
16:16
02/24/18
16:16
Periodicals
Berkshire Hathaway reports record profit fueled by tax reform, Reuters says »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$32.66

0.55 (1.71%)

16:12
02/24/18
02/24
16:12
02/24/18
16:12
Periodicals
Twitter's SoundCloud investment officially wiped out, Recode reports »

Twitter has written off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

AAPL

Apple

$175.50

3 (1.74%)

16:08
02/24/18
02/24
16:08
02/24/18
16:08
Periodicals
Apple to store sensitive encryption keys in China, WSJ reports »

Apple will start to store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$40.98

0.09 (0.22%)

16:00
02/24/18
02/24
16:00
02/24/18
16:00
Periodicals
Volkswagen's U.S. unit settles emissions suit, Reuters reports »

Volkswagen's unit in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.46

0.91 (1.73%)

, UAL

United Continental

$67.57

0.87 (1.30%)

15:56
02/24/18
02/24
15:56
02/24/18
15:56
Periodicals
Delta, United Airlines cut ties with NRA, Reuters reports »

Delta Air Lines (DAL) and…

DAL

Delta Air Lines

$53.46

0.91 (1.73%)

UAL

United Continental

$67.57

0.87 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 30

    May

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

, BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

15:53
02/24/18
02/24
15:53
02/24/18
15:53
Earnings
Berkshire Hathaway reports Q4 operating EPS $3,338, consensus $2,622.23 »

Reports FY17 operating…

BRK.A

Berkshire Hathaway

$304,020.01

2616.01 (0.87%)

BRK.B

Berkshire Hathaway

$202.76

2.03 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$94.70

0.33 (0.35%)

, T

AT&T

$36.72

0.25 (0.69%)

15:44
02/24/18
02/24
15:44
02/24/18
15:44
Periodicals
May be time to consider Time Warner, Barron's says »

Time Warner (TWX) shares…

TWX

Time Warner

$94.70

0.33 (0.35%)

T

AT&T

$36.72

0.25 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 23

    Apr

JKHY

Jack Henry

$121.95

1.79 (1.49%)

12:59
02/24/18
02/24
12:59
02/24/18
12:59
Conference/Events
Jack Henry management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

PFBC

Preferred Bank

$64.05

0.86 (1.36%)

12:52
02/24/18
02/24
12:52
02/24/18
12:52
Conference/Events
Preferred Bank management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 13

    Mar

  • 24

    Sep

R

Ryder

$74.54

0.19 (0.26%)

12:47
02/24/18
02/24
12:47
02/24/18
12:47
Conference/Events
Ryder management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

ASPU

Aspen Group

$8.85

1.48 (20.08%)

12:29
02/24/18
02/24
12:29
02/24/18
12:29
Conference/Events
Aspen Group to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

TWTR

Twitter

$32.66

0.55 (1.71%)

, AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

10:47
02/24/18
02/24
10:47
02/24/18
10:47
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWTR

Twitter

$32.66

0.55 (1.71%)

AOBC

American Outdoor Brands

$10.00

-0.12 (-1.19%)

RGR

Sturm, Ruger

$49.90

0.9 (1.84%)

X

U.S. Steel

$43.52

0.54 (1.26%)

STLD

Steel Dynamics

$47.47

-0.53 (-1.10%)

NUE

Nucor

$66.94

-0.01 (-0.01%)

AKS

AK Steel

$5.50

-0.12 (-2.14%)

AET

Aetna

$175.55

0.49 (0.28%)

ANTM

Anthem

$235.24

1.56 (0.67%)

CNC

Centene

$100.45

0.96 (0.96%)

CI

Cigna

$194.79

2.89 (1.51%)

HNT

Health Net

HUM

Humana

$271.19

3.38 (1.26%)

MOH

Molina Healthcare

$72.94

1.38 (1.93%)

UNH

UnitedHealth

$230.16

3.07 (1.35%)

WCG

WellCare

$192.05

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 07

    Mar

  • 13

    Mar

  • 16

    Apr

  • 30

    May

DBX

Dropbox

, SNAP

Snap

$17.45

-0.06 (-0.34%)

09:49
02/24/18
02/24
09:49
02/24/18
09:49
Periodicals
Dropbox IPO bodes well, Barron's says »

In a follow-up article…

DBX

Dropbox

SNAP

Snap

$17.45

-0.06 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

IPG

Interpublic Group

$24.24

0.3 (1.25%)

, OMC

Omnicom

$77.31

0.52 (0.68%)

09:42
02/24/18
02/24
09:42
02/24/18
09:42
Periodicals
Advertising companies cheaper than usual, Barron's says »

After a tumble last year,…

IPG

Interpublic Group

$24.24

0.3 (1.25%)

OMC

Omnicom

$77.31

0.52 (0.68%)

PUBGY

Publicis

$18.82

0.09 (0.48%)

WPP

WPP

$95.30

0.93 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 05

    Mar

MSFT

Microsoft

$94.06

2.33 (2.54%)

, INTC

Intel

$47.73

1.93 (4.21%)

09:36
02/24/18
02/24
09:36
02/24/18
09:36
Periodicals
Quantum computing soon to be reality, Barron's says »

Microsoft (MSFT) predicts…

MSFT

Microsoft

$94.06

2.33 (2.54%)

INTC

Intel

$47.73

1.93 (4.21%)

NVDA

Nvidia

$245.93

3.78 (1.56%)

MU

Micron

$46.53

2.28 (5.15%)

GOOG

Alphabet

$1,126.79

20.16 (1.82%)

GOOGL

Alphabet Class A

$1,128.09

18.19 (1.64%)

AMZN

Amazon.com

$1,500.00

14.66 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

AMZN

Amazon.com

$1,500.00

14.66 (0.99%)

09:26
02/24/18
02/24
09:26
02/24/18
09:26
Periodicals
Many downsides when Amazon's HQ2 comes to town, Barron's says »

As Amazon decides on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

BHGE

Baker Hughes

$28.03

-0.01 (-0.04%)

04:55
02/24/18
02/24
04:55
02/24/18
04:55
Conference/Events
Baker Hughes management to meet with UBS »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

GE

General Electric

$14.49

-0.01 (-0.07%)

18:49
02/23/18
02/23
18:49
02/23/18
18:49
Periodicals
General Electric could face DOJ action over subprime mortgages, Reuters says »

General Electric may face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$20.15

0.34 (1.72%)

18:30
02/23/18
02/23
18:30
02/23/18
18:30
Syndicate
Bright Scholar files to sell 10M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

, CMD

Cantel Medical

$115.34

2.45 (2.17%)

18:03
02/23/18
02/23
18:03
02/23/18
18:03
Periodicals
J&J sterilization unit draws bids from Cantel Medical, Medtronic, Bloomberg says »

Cantel Medical (CMD) and…

JNJ

Johnson & Johnson

$132.02

2.11 (1.62%)

CMD

Cantel Medical

$115.34

2.45 (2.17%)

MDT

Medtronic

$80.39

-0.02 (-0.02%)

KKR

KKR

$21.96

0.18 (0.83%)

CG

Carlyle Group

$23.15

-0.1 (-0.43%)

MMM

3M

$237.02

1.02 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 14

    Mar

  • 23

    Mar

  • 23

    Apr

  • 30

    May

AET

Aetna

$175.55

0.49 (0.28%)

, CVS

CVS Health

$68.16

0.16 (0.24%)

18:00
02/23/18
02/23
18:00
02/23/18
18:00
Hot Stocks
Aetna: CVS deal part of long-term solution toward value-based system »

According to prepared…

AET

Aetna

$175.55

0.49 (0.28%)

CVS

CVS Health

$68.16

0.16 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 30

    May

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:56
02/23/18
02/23
17:56
02/23/18
17:56
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$2.60

0.0301 (1.17%)

17:55
02/23/18
02/23
17:55
02/23/18
17:55
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.